Evaluation of Commiphora Myrrh Versus Sodium Hypochlorite as Root Canal Irrigant on Post- Operative Pain and Bacterial Load Reduction in Symptomatic Mandibular Premolar Teeth With Necrotic Pulp. (A Randomized Clinical Trial)
Evaluation of Commiphora Myrrh Versus Sodium Hypochlorite as Root Canal Irrigant on Post- Operative Pain and Bacterial Load Reduction in Symptomatic Mandibular Premolar Teeth With Necrotic Pulp. (A Randomized Clinical Trial)
Clinically compare the post-operative pain , incidences post-operative swelling , post-operative number of analgesic tablets taken by patient and amount of bacterial load reduction after using 50% Commiphora Myrrh Chemomechanical preparation , versus 2.5% NaOCl,in asymptomatic necrotic mandibular premolar treated in single visit.
The patients will be randomly divided into 2 groups. Intervention group (50% Commiphora Myrrh solution root canal irrigant) and control group (2.5% sodium hypochlorite root canal irrigant)
Post-operative pain will be measured at 6,12,24,48 hours post-operatively The pain will be recorded using numerical rating scale
Post-operative swelling will be measured at 6,12,24,48 hours post-operatively The swelling will be receded using visual swelling rating scale
Number of analgesic tablets taken by the patient post-operatively. Up to 48 hours
Amount of bacteria load reduction The intracanal bacterial load reduction will be determined using agar culture technique by counting the colony forming units per milliliter (CFI /ml) before and after root canal preparation.
Inclusion Criteria:
Systemically healthy patient (ASA I, II).
Age between 20 and 40 years.
Male or female.
Patient who is able to sign and comprehend the pain scale (committed patient).
Mandibular single rooted premolars having the following criteria:
Exclusion Criteria:
Medically compromised patients (ASA III or IV).
Teeth with:
Patients who could not interpret the NRS.
Patients with diabetes, immune-compromising, and immunosuppression disease and pregnant women will be also excluded.
History of intolerance to NSAIDs.
rahaf.manzlawi@dentistry.cu.edu.eg01150019478 ext. +20